跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial - HSA Drug Approval Details
Approvals
/
HSA
/
K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial
Approved
THERAPEUTIC
K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial
KOREA UNITED PHARMACEUTICAL INC
🇸🇬 Health Sciences Authority
Approval Date
Jun 26, 1999
Approval ID
3d191b95969d67e2
Company
KOREA UNITED PHARMACEUTICAL INC
Type
Therapeutic
Approval Details
Approval Id
3d191b95969d67e2
Drug Name
K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial
Product Name
K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial
Approval Number
SIN10991P
Approval Date
1999-06-26
Registrant
SHOEI UNIVERSAL CORPORATION PTE LTD
Licence Holder
SHOEI UNIVERSAL CORPORATION PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01DB01
Atc Item Name
doxorubicin
Pharma Manufacturer Name
SHOEI UNIVERSAL CORPORATION PTE LTD
Company Detail Path
/organization/shoei-universal-corporation-pte-ltd
Active Ingredients
DOXORUBICIN HCl EQV DOXORUBICIN
50 mg/vial
DOXORUBICIN HCl EQV DOXORUBICIN
50 mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 26, 1999
Approval ID
3d191b95969d67e2
Type
Therapeutic
Back to HSA Approvals
